Cited by 347Amyotrophic Lateral Sclerosis ResearchGenetic Neurodegenerative DiseasesAlzheimer's disease research and treatments

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations

Open access

Mackenzie, Ian R., Arzberger, Thomas, Kremmer, Elisabeth, Troost, Dirk, Lorenzl, Stefan, Mori, Kohji, Weng, Shih-Ming, Haass, Christian, Kretzschmar, Hans A., Edbauer, Dieter, Neumann, Manuela·2013·Acta Neuropathologica

DOI 10.1007/s00401-013-1181-y

Open this paper in CoChat — free account

Abstract

Hexanucleotide repeat expansion in C9ORF72 is the most common genetic cause of frontotemporal dementia and motor neuron disease. Recently, unconventional non-ATG translation of the expanded hexanucleotide repeat, resulting in the production and aggregation of dipeptide repeat (DPR) proteins (poly-GA, -GR and GP), was identified as a potential pathomechanism of C9ORF72 mutations. Besides accumulation of DPR proteins, the second neuropathological hallmark lesion in C9ORF72 mutation cases is the accumulation of TDP-43. In this study, we characterized novel monoclonal antibodies against poly-GA and performed a detailed analysis of the neuroanatomical distribution of DPR and TDP-43 pathology in a cohort of 35 cases with the C9ORF72 mutation that included a broad spectrum of clinical phenotypes. We found the pattern of DPR pathology to be highly consistent among cases regardless of the phenotype with high DPR load in the cerebellum, all neocortical regions (frontal, motor cortex and occipital) and hippocampus, moderate pathology in subcortical areas and minimal pathology in lower motor neurons. No correlation between DPR pathology and the degree of neurodegeneration was observed, while a good association between TDP-43 pathology with clinical phenotype and degeneration in key anatomical regions was present. Our data confirm that the presence of DPR pathology is intimately related to C9ORF72 mutations. The observed dissociation between DPR inclusion body load and neurodegeneration might suggest inclusion body formation as a potentially protective response to cope with soluble toxic DPR species. Moreover, our data imply that alterations due to the C9ORF72 mutation resulting in TDP-43 accumulation and dysmetabolism as secondary downstream effects likely play a central role in the neurodegenerative process in C9ORF72 pathogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s00401-013-1181-y

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Self-citation
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · cited 4×
“The number of hexanucleotide repeats in the normal population ranges from 2 to 24 [13, 14, 17, 31, 39], whereas up to several thousand repeats (range 700–4,400 repeats) are described in the pathologically expanded allele as estimated by Southern blot analysis [5, 13, 14].”
BackgroundMethodInfluentialSelf-citation
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050 · cited 1×
“Based on the observations that there is sometimes only poor correlation between the neuropathological hallmark lesions seen with neurodegeneration or phenotype, with the most prominent examples perhaps being the rather poor association of amyloid beta load with cognitive impairments [27] and intranuclear inclusions in…”
BackgroundSelf-citation
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., & Finkbeiner, S. (2004) · Nature · doi:10.1038/nature02998 · Cited by 1,979
The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS
Mori, K., Weng, S., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H. A., Cruts, M., Broeckhoven, C. V., et al. (2013) · Science · doi:10.1126/science.1232927 · Cited by 1,248
Self-citation
Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS
Ash, P. E. A., Bieniek, K. F., Gendron, T. F., Caulfield, T. R., Lin, W.-L., DeJesus‐Hernandez, M., van Blitterswijk, M., Jansen‐West, K. R., Paul, J. W., Rademakers, R., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.004 · Cited by 1,127
A harmonized classification system for FTLD-TDP pathology
Mackenzie, I. R., Neumann, M., Baborie, A., Sampathu, D. M., du Plessis, D., Jaros, E., Perry, R. H., Trojanowski, J. Q., Mann, D. M. A., & Lee, V. M. ‐. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0845-8 · Cited by 1,042
Self-citation
Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations
Mackenzie, I. R. A., Bigio, E. H., Ince, P. G., Geser, F., Neumann, M., Cairns, N. J., Kwong, L. K., Forman, M. S., Ravits, J., Stewart, H., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21147 · Cited by 992
Self-citation
Non-ATG–initiated translation directed by microsatellite expansions
Zu, T., Gibbens, B. B., Doty, N. S., Gomes-Pereira, M., Huguet-Lachon, A., Stone, M. D., Margolis, J., Peterson, M., Markowski, T. W., Ingram, M. A. C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013343108 · Cited by 928

Show all 41 references

Sorted by citations

Items 201–300 of 347

Transcriptional targets of amyotrophic lateral sclerosis/frontotemporal dementia protein TDP-43 – meta-analysis and interactive graphical database
Cao, M. C., & Scotter, E. L. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049418 · Cited by 25
C9ORF72 protein function and immune dysregulation in amyotrophic lateral sclerosis
Lai, J. D., & Ichida, J. K. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134523 · Cited by 25
Modeling neuromuscular diseases in zebrafish
Singh, J., & Patten, S. A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1054573 · Cited by 21
How villains are made: The translation of dipeptide repeat proteins in C9ORF72-ALS/FTD
Spijker, H. M. V. ‘., & Almeida, S. (2023) · Gene · doi:10.1016/j.gene.2023.147167 · Cited by 22
Amyotrophic lateral sclerosis and non-tau frontotemporal lobar degeneration
Hortobágyi, T., & Cairns, N. J. (2017) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802395-2.00026-2 · Cited by 19
Repeat-associated non-AUG (RAN) translation mechanisms are running into focus for GGGGCC-repeat associated ALS/FTD
Goodman, L. D., & Bonini, N. M. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101697 · Cited by 20
The MuSK agonist antibody protects the neuromuscular junction and extends the lifespan in C9orf72-ALS mice
Sun, S., Shen, Y., Zhang, X., Ding, N., Xu, Z., Zhang, Q., & Li, L. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.05.016 · Cited by 19
Role of C9orf72 hexanucleotide repeat expansions in ALS/FTD pathogenesis
Geng, Y., & Cai, Q. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1322720 · Cited by 20
Neurodegenerative disorders of the human frontal lobes
Butler, P. M., & Chiong, W. (2019) · Handbook of clinical neurology · doi:10.1016/b978-0-12-804281-6.00021-5 · Cited by 20
Drosophila models of amyotrophic lateral sclerosis with defects in RNA metabolism
Zhang, K., Coyne, A. N., & Lloyd, T. E. (2018) · Brain Research · doi:10.1016/j.brainres.2018.04.043 · Cited by 21
C9orf72; abnormal RNA expression is the key
Heutink, P., Jansen, I. E., & Lynes, E. M. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.05.020 · Cited by 17
Repeated mild traumatic brain injury triggers pathology in asymptomatic C9ORF72 transgenic mice
Kahriman, A., Bouley, J., Tuncali, I., Dogan, E. O., Pereira, M., Luu, T., Bosco, D. A., Jaber, S., Peters, O. M., Brown, R. H., et al. (2023) · Brain · doi:10.1093/brain/awad264 · Cited by 18
Therapeutic Targeting of Proteostasis in Amyotrophic Lateral Sclerosis—a Systematic Review and Meta-Analysis of Preclinical Research
Elliott, E., Bailey, O., Waldron, F. M., Hardingham, G. E., Chandran, S., & Gregory, J. M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00511 · Cited by 15
Impaired ribosome-associated quality control of C9orf72 arginine-rich dipeptide-repeat proteins
Viera-Ortiz, A., Cajka, G. G., Olatunji, O. A., Mikytuck, B., Shalem, O., & Lee, E. B. (2022) · Brain · doi:10.1093/brain/awac479 · Cited by 17
Abnormal expression of homeobox genes and transthyretin in C9ORF72 expansion carriers
Finch, N. A., Wang, X., Baker, M., Heckman, M. G., Gendron, T. F., Bieniek, K. F., Wuu, J., DeJesus‐Hernandez, M., Brown, P. H., Chew, J., et al. (2017) · Neurology Genetics · doi:10.1212/nxg.0000000000000161 · Cited by 17
pTDP-43 levels correlate with cell type–specific molecular alterations in the prefrontal cortex of C9orf72 ALS/FTD patients
Wang, H. V., Xiang, J., Yuan, C., Veire, A. M., Gendron, T. F., Murray, M. E., Tansey, M. G., Hu, J., Gearing, M., Glass, J. D., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2419818122 · Cited by 15
Modelling C9orf72-Related Amyotrophic Lateral Sclerosis in Zebrafish
Fortier, G., Butti, Z., & Patten, S. A. (2020) · Biomedicines · doi:10.3390/biomedicines8100440 · Cited by 15
Rab-dependent cellular trafficking and amyotrophic lateral sclerosis
Parakh, S., Perri, E. R., Jagaraj, C. J., Ragagnin, A., & Atkin, J. D. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1553926 · Cited by 15
Cognitive Syndromes and C9orf72 Mutation Are Not Related to Cerebellar Degeneration in Amyotrophic Lateral Sclerosis
Consonni, M., Bella, E. D., Nigri, A., Pinardi, C., Demichelis, G., Porcu, L., Gellera, C., Pensato, V., Cappa, S. F., Bruzzone, M. G., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00440 · Cited by 15
Elucidating the Role of Cerebellar Synaptic Dysfunction in C9orf72-ALS/FTD — a Systematic Review and Meta-Analysis
Kaliszewska, A., Allison, J., Col, T.-T., Shaw, C. E., & Arias, N. (2021) · The Cerebellum · doi:10.1007/s12311-021-01320-0 · Cited by 15
Dipeptide repeat protein and TDP-43 pathology along the hypothalamic–pituitary axis in C9orf72 and non-C9orf72 ALS and FTLD-TDP cases
Dedeene, L., Schoor, E. V., Ospitalieri, S., Ronisz, A., Weishaupt, J. H., Otto, M., Ludolph, A. C., Scheuerle, A., Vandenberghe, R. R., Damme, P. V., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02216-9 · Cited by 14
CRISPR-Cas9 targeted deletion of the C9orf72 repeat expansion mutation corrects cellular phenotypes in patient-derived iPS cellsPreprint
Pribadi, M., Yang, Z., Kim, T. S., Swartz, E. W., Huang, A., Chen, J., Dokuru, D. R., Baek, J., Gao, F., Fua, A., et al. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/051193 · Cited by 15
Correction of dysregulated lipid metabolism normalizes gene expression in oligodendrocytes and prolongs lifespan in female poly-GA C9orf72 mice
Rezaei, A., Kocsis-Jutka, V., Gunes, Z. I., Zeng, Q., Kislinger, G., Bauernschmitt, F., Isilgan, H. B., Parisi, L. R., Kaya, T., Franzenburg, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58634-4 · Cited by 14
Self-citation
Distribution of ubiquilin 2 and TDP ‐43 aggregates throughout the CNS in UBQLN2 p. T487I ‐linked amyotrophic lateral sclerosis and frontotemporal dementia
Nementzik, L. R., Thumbadoo, K. M., Murray, H. C., Gordon, D., Yang, S., Blair, I. P., Turner, C. P., Faull, R. L. M., Curtis, M. A., McLean, C., et al. (2023) · Brain Pathology · doi:10.1111/bpa.13230 · Cited by 11
Coexisting Lewy body disease and clinical parkinsonism in amyotrophic lateral sclerosis
Forrest, S. L., Kim, J. H., Sousa, C. D., Cheong, R., Crockford, D. R., Sheedy, D. L., Stevens, J., McCrossin, T., Tan, R. H., McCann, H., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.14849 · Cited by 13
Parkin beyond Parkinson’s Disease—A Functional Meaning of Parkin Downregulation in TDP-43 Proteinopathies
Gawęda-Walerych, K., Sitek, E. J., Narożańska, E., & Buratti, E. (2021) · Cells · doi:10.3390/cells10123389 · Cited by 13
Motor neurone disease/amyotrophic lateral sclerosis associated with intermediate‐length CAG repeat expansions in Ataxin‐2 does not have 1 C 2‐positive polyglutamine inclusions
Highley, J. R., Lorente-Pons, A., Cooper‐Knock, J., Wharton, S. B., Ince, P. G., Shaw, P. J., Wood, J. D., & Kirby, J. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12254 · Cited by 12
Drosophila as a Model to Gain Insight into the Role of lncRNAs in Neurological Disorders
Lo Piccolo, L. (2018) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-0529-0_8 · Cited by 13
ALS’ Perfect Storm: C9orf72-Associated Toxic Dipeptide Repeats as Potential Multipotent Disruptors of Protein Homeostasis
Smeele, P. H., Cesare, G., & Vaccari, T. (2024) · Cells · doi:10.3390/cells13020178 · Cited by 12
eIF5 stimulates the CUG initiation of RAN translation of poly-GA dipeptide repeat protein (DPR) in C9orf72 FTLD/ALS
Gotoh, S., Mori, K., Fujino, Y., Kawabe, Y., Yamashita, T., Omi, T., Nagata, K., Tagami, S., Nagai, Y., & Ikeda, M. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.105703 · Cited by 12
Self-citation
Hippocampal aggregation signatures of pathogenic UBQLN2 in amyotrophic lateral sclerosis and frontotemporal dementia
Thumbadoo, K. M., Dieriks, B. V., Murray, H. C., Swanson, M. E. V., Yoo, J. H., Mehrabi, N. F., Turner, C. P., Dragunow, M., Faull, R. L. M., Curtis, M. A., et al. (2024) · Brain · doi:10.1093/brain/awae140 · Cited by 13
Intermediate length C9orf72 expansion in an ALS patient without classical C9orf72 neuropathology
Beer, A. M., Cooper‐Knock, J., Higginbottom, A., Highley, J. R., Wharton, S. B., Ince, P. G., Milano, A., Jones, A., Al‐Chalabi, A., Kirby, J., et al. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.977296 · Cited by 12
Dissecting Motor Neuron Disease With Drosophila melanogaster
Walters, R., Manion, J., & Neely, G. G. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00331 · Cited by 12
C9ORF72 knockdown triggers FTD-like symptoms and cell pathology in mice
Lopez-Herdoiza, M.-B., Bauché, S., Wilmet, B., Duigou, C. L., Roussel, D., Frah, M., Béal, J., Devely, G., Boluda, S., Frick, P., et al. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1155929 · Cited by 13
Self-citation
Reversal of C9orf72 mutation-induced transcriptional dysregulation and pathology in cultured human neurons by allele-specific excision
Sachdev, A., Gill, K., Sckaff, M., Birk, A. M., Arogundade, O. A., Brown, K. A., Chouhan, R. S., Issagholian-Lewin, P. O., Patel, E. M., Watry, H. L., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2307814121 · Cited by 12
Reduction of oxidative stress suppresses poly-GR-mediated toxicity in zebrafish embryos
Riemslagh, F. W., Verhagen, R. F. M., van der Toorn, E. C., Smits, D. J., Quint, W. H., van der Linde, H. C., van Ham, T. J., & Willemsen, R. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.049092 · Cited by 12
C9ORF72 repeat‐associated non‐ ATG ‐translated polypeptides are distributed independently of TDP ‐43 in a J apanese patient with c9 ALS
Konno, T., Tada, M., Shiga, A., Tsujino, A., Eguchi, H., Masuda‐Suzukake, M., Hasegawa, M., Nishizawa, M., Onodera, O., Kakita, A., et al. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12157 · Cited by 11
C9ORF72in Dementia with Lewy bodies
Robinson, A., Davidson, Y. S., Snowden, J. S., & Mann, D. M. A. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-307622 · Cited by 11
Distinct neurological disorders with C9orf72 mutations: genetics, pathogenesis, and therapy
Chi, S., Jiang, T., Tan, L., & Yu, J. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.033 · Cited by 12
Dipeptide repeat protein toxicity in frontotemporal lobar degeneration and in motor neurone disease associated with expansions in C9ORF72—a cautionary note
Mann, D. M. A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.011 · Cited by 13
Insights into disease mechanisms and potential therapeutics for C9orf72-related amyotrophic lateral sclerosis/frontotemporal dementia
Gagliardi, D., Costamagna, G., Taiana, M. M., Andreoli, L., Biella, F., Bersani, M., Bresolin, N., Comi, G. P., & Corti, S. P. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101172 · Cited by 11
Fluid Biomarkers of Frontotemporal Lobar Degeneration
van der Ende, E. L., & Swieten, J. C. V. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-51140-1_9 · Cited by 11
Modeling C9orf72-Related Frontotemporal Dementia and Amyotrophic Lateral Sclerosis in Drosophila
Sharpe, J. L., Harper, N. S., Garner, D. R., & West, R. J. H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.770937 · Cited by 14
Biological basis and psychiatric symptoms in frontotemporal dementia
Mori, K., & Ikeda, M. (2022) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13375 · Cited by 12
Self-citation
PTPσ-mediated PI3P regulation modulates neurodegeneration in C9ORF72-ALS/FTD
Zhang, Z., Fu, X., Wright, N., Wang, W., Ye, Y., Asbury, J., Li, Y., Zhu, C., Wu, R., Wang, S., et al. (2025) · Neuron · doi:10.1016/j.neuron.2025.02.005 · Cited by 9
Validated assays for the quantification of C9orf72 human pathology
Salomonsson, S. E., Birk, A. M., Gill, K., Arogundade, O. A., Brown, K. A., Sachdev, A., Sckaff, M., Lam, K. J. K., Fisher, I., Chouhan, R. S., et al. (2024) · Scientific Reports · doi:10.1038/s41598-023-50667-3 · Cited by 10
Molecular Mechanisms of Amyotrophic Lateral Sclerosis
Collins, M. A., & Bowser, R. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802257-3.00004-3 · Cited by 10
New routes in frontotemporal dementia drug discovery
Conti, L. D., Borroni, B., & Baralle, M. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1329294 · Cited by 10
Role of the C9ORF72 Gene in the Pathogenesis of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Hao, Z., Wang, R., Ren, H., & Wang, G. (2020) · Neuroscience Bulletin · doi:10.1007/s12264-020-00567-7 · Cited by 11
Blood-based Biomarkers for Amyotrophic Lateral Sclerosis
Wilkins, H., Dimachkie, M. M., & Aǵbaş, A. (2021) · Exon Publications eBooks · doi:10.36255/exonpublications.amyotrophiclateralsclerosis.biomarkers.2021 · Cited by 11
Amyotrophic lateral sclerosis and frontotemporal lobar degeneration
Hortobágyi, T., & Cairns, N. J. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107588660.012 · Cited by 10
The Role of White Matter Dysfunction and Leukoencephalopathy/Leukodystrophy Genes in the Aetiology of Frontotemporal Dementias: Implications for Novel Approaches to Therapeutics
Lok, H. C., & Kwok, J. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052541 · Cited by 10
Proteostasis deregulation as a driver of C9ORF72 pathogenesis
Torres, P., Cabral‐Miranda, F., Gonzalez‐Teuber, V., & Hetz, C. A. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15529 · Cited by 9
Models and mechanisms of repeat expansion disorders: a worm’s eye view
Rudich, P. D., & Lamitina, T. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0950-8 · Cited by 10
Frontotemporal dementia
Perry, D. C., & Rosen, H. J. (2016) · Wiley eBooks · doi:10.1002/9781118797662.ch5 · Cited by 9
Frontotemporal lobar dementia and amyotrophic lateral sclerosis associated with c9orf72 expansion
Ber, I. L. (2015) · Revue Neurologique · doi:10.1016/j.neurol.2015.04.004 · Cited by 8
Immunohistochemical detection of C9orf72 protein in frontotemporal lobar degeneration and motor neurone disease: patterns of immunostaining and an evaluation of commercial antibodies
Davidson, Y. S., Robinson, A., Rollinson, S. J., Pickering-Brown, S. M., Xiao, S., Robertson, J., & Mann, D. M. A. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1359304 · Cited by 8
Reduced mtDNA Copy Number in the Prefrontal Cortex of C9ORF72 Patients
Álvarez‐Mora, M. I., Podlesniy, P., Riazuelo, T., Molina‐Porcel, L., Gelpí, E., & Rodríguez‐Revenga, L. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02673-7 · Cited by 8
C9orf72 poly-GA proteins impair neuromuscular transmission
Tu, W.-Y., 浙江大学转化医学研究院, 医., Xu, W., Zhang, J., Qi, S., Bai, L., Shen, C., Zhang, K., & 浙江大学教育部脑与脑机融合前沿科学中心, 浙. 杭. 3. (2023) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2022.356 · Cited by 10
RNA versus protein toxicity in C9orf72 ALS/FTLD
Arzberger, T., Schludi, M. H., Lehmer, C., Schmid, B., & Edbauer, D. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1823-1 · Cited by 9
Self-citation
Association of TMEM106B rs1990622 Marker and Frontotemporal Dementia: Evidence for a Recessive Effect and Meta-Analysis
Hernández, I., Rosende‐Roca, M., Alegret, M., Mauleón, A., Espinosa, A., Vargas, L., Sotolongo‐Grau, Ó., Tárraga, L., Boada, M., & Ruiz, A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-132432 · Cited by 8
Differential neuronal vulnerability to C9orf72 repeat expansion driven by Xbp1-induced endoplasmic reticulum-associated degradation
Shen, D., Vincent, A. J., Udine, E., Buhidma, Y., Anoar, S., Tsintzas, E., Maeland, M. E., Xu, D., Carcolé, M., Osumi-Sutherland, D., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115459 · Cited by 9
Preclinical and Prodromal Frontotemporal Dementia: Challenges and Opportunities
Palacino, F., Manganotti, P., & Benussi, A. (2025) · International Journal of Translational Medicine · doi:10.3390/ijtm5040052 · Cited by 7
Genetic ablation of Sarm1 attenuates expression and mislocalization of phosphorylated TDP-43 after mouse repetitive traumatic brain injury
Dogan, E. O., Bouley, J., Zhong, J., Harkins, A. L., Keeler, A. M., Bosco, D. A., Brown, R. H., & Henninger, N. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01709-4 · Cited by 7
The contribution of proteasomal impairment to autophagy activation by C9orf72 poly-GA aggregates
Pu, M., Tai, Y., Yuan, L., Zhang, Y., Guo, H., Hao, Z., Chen, J., Qi, X., Wang, G., Tao, Z., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04518-5 · Cited by 11
Multi-scale neural homeostasis mechanisms: Insights into neurodegenerative diseases and therapeutic approaches, including exercise
Wang, Y., Chen, X., Zhang, C., & Gao, S. (2025) · Advanced Exercise and Health Science · doi:10.1016/j.aehs.2025.02.002 · Cited by 8
Current neuroprotective therapies and future prospects for motor neuron disease
Evans, L. J., O’Brien, D., & Shaw, P. J. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.04.003 · Cited by 5
Nanoscopic investigation of C9orf72 poly-GA oligomers on nuclear membrane disruption by a photoinducible platform
Chien, H.-M., He, R., Lee, C.-C., Huang, Y., Hung, I.-J., Hou, K.-T., Hsiao, J., Lu, P.-C., Agnihotri, D., Hwang, E., et al. (2021) · Communications Chemistry · doi:10.1038/s42004-021-00547-6 · Cited by 5
Aspects of degradation and translation of the expanded C9orf72 hexanucleotide repeat RNA
Mori, K., Gotoh, S., & Ikeda, M. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15847 · Cited by 6
Self-citation
C9orf72-specific phenomena associated with frontotemporal dementia and gastrointestinal symptoms in the absence of TDP-43 aggregation
Sampognaro, P. J., Vatsavayai, S. C., Cosme, C. G., Hwang, J., Nolan, A., Huang, E. J., Seeley, W. W., & May, M. G. D. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02084-y · Cited by 6
BV-2 Microglial Cells Overexpressing C9orf72 Hexanucleotide Repeat Expansion Produce DPR Proteins and Show Normal Functionality but No RNA Foci
Rostalski, H., Hietanen, T., Leskelä, S., Beháňová, A., Abdollahzadeh, A., Wittrahm, R., Mäkinen, P. M., Huber, N., Hoffmann, D. B., Solje, E., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.550140 · Cited by 5
Cellular and molecular phenotypes of C9orf72 ALS/FTD patient derived iPSC-microglia mono-culturesPreprint
Lorenzini, I., Alsop, E. B., Levy, J., Gittings, L. M., Lall, D., Rabichow, B. E., Moore, S. R., Pevey, R. S., Bustos, L. M., Burciu, C., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.03.277459 · Cited by 6
Frontotemporal dementia
Wauters, E., Sleegers, K., Cruts, M., & Broeckhoven, C. V. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-805120-7.00009-9 · Cited by 6
Genome-Encoded Cytoplasmic Double-Stranded RNAs, Found in C9ORF72 ALS-FTD Brain, Provoke Propagated Neuronal DeathPreprint
Rodriguez, S., Schrank, B. R., Şahin, A., Lawati, H. J. A., Costantino, I. M., Benz, E. G., Fard, D., Albers, A. D., Cao, L., Gomez, A. C., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/248328 · Cited by 5
A multimodal screening platform for endogenous dipeptide repeat proteins in C9orf72 patient iPSC neurons
Hölbling, B. V., Gupta, Y., Marchi, P. M., Atilano, M. L., Flower, M. D., Ureña, E., Goulden, R. A., Dobbs, H. K., Katona, E., Mikheenko, A., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115695 · Cited by 5
Cognitive Decline in Parkinsonism: From Clinical Phenotypes to the Genetic Background
Koros, C., Stanitsa, E., Angelopoulou, E., Papageorgiou, S. G., & Stefanis, L. (2025) · Biomedicines · doi:10.3390/biomedicines13071624 · Cited by 5
Frontotemporal dementia patient-derived iPSC neurons show cell pathological hallmarks and evidence for synaptic dysfunction and DNA damage
Huber, N., Hietanen, T., Heikkinen, S., Shakirzyanova, A., Hoffmann, D. B., Rostalski, H., Dhingra, A., Rodrı́guez-Nieto, S., Kärkkäinen, S., Koskuvi, M., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03272-x · Cited by 5
Development and Preclinical Evaluation of a Copper-64-Labeled Antibody Targeting Glycine-Alanine Dipeptides for PET Imaging of C9orf72-Associated Amyotrophic Lateral Sclerosis/Frontotemporal Dementia
Shojaei, M., Zhou, Q., Palumbo, G., Schaefer, R., Kaskinoro, J., Vehmaan-Kreula, P., Bartenstein, P., Brendel, M., Edbauer, D., & Lindner, S. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00037 · Cited by 4
Self-citation
Pathology and pathophysiology
Dickerson, B. C. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781316091586.016 · Cited by 4
The mTORC2/AKT/VCP axis is associated with quality control of the stalled translation of poly(GR) dipeptide repeats in C9-ALS/FTD
Li, Y., Geng, J., Rimal, S., Wang, H., Liu, X., Lu, B., & Li, S. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.102995 · Cited by 4
Genetics of Amyotrophic Lateral Sclerosis
Kenna, K. P., Landers, J. E., & Ticozzi, N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802257-3.00003-1 · Cited by 4
The role of dipeptide‐repeat protein pathology in C9orf72 mutation cases
Mackenzie, I. R. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12296 · Cited by 4
Self-citation
Gel-like inclusions of C-terminal fragments of TDP-43 sequester and inhibit proteasomes in neuronsPreprint
Riemenschneider, H., Guo, Q., Bader, J. M., Frottin, F., Farny, D., Kleinberger, G., Haass, C., Mann, M., Hartl, F. U., Baumeister, W. P., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.15.435268 · Cited by 4
Self-citation
Two therapeutic CRISPR/Cas9 gene editing approaches revert FTD/ALS cellular pathology caused by a C9orf72 repeat expansion mutation in patient derived cellsPreprint
Sckaff, M., Gill, K., Sachdev, A., Birk, A. M., Arogundade, O. A., Watry, H., Keough, K. C., Tsai, Y.-C., Ziegle, J. S., Conklin, B. R., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.21.492887 · Cited by 4
PU.1 restores microglial dysfunction caused by C9ORF72 repeat expansions in neural organoids
Ljubikj, T., Mars, M., van der Geest, A. T., Jakobs, C. E., Bessler, N., Donega, V., van den Oetelaar, X. P. R. M., de Wit, M., & Pasterkamp, R. J. (2025) · Brain · doi:10.1093/brain/awaf340 · Cited by 4
CRISPR interference to evaluate modifiers of C9ORF72-mediated toxicity in FTD
Pickles, S. R., Alepuz, D. Z., Koike, Y. M., Yue, M., Tong, J., Liu, P., Zhou, Y., Jansen‐West, K. R., Daughrity, L. M., Song, Y., et al. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1251551 · Cited by 4
Activated Fibroblast Growth Factor Receptor 1 Mitigated Poly-PR-Induced Oxidative Stress and Protein Translational Impairment.
Ito, T., Ohuchi, K., Kurita, H., Murakami, T., Takizawa, S., Fujimaki, A., Murata, J., Oida, Y., Hozumi, I., Kitaichi, K., et al. (2025) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b24-00794 · Cited by 3
Basic Concepts and Emergent Disease Mechanisms of Amyotrophic Lateral Sclerosis
Sirozh, O., Sáez-Mas, A., Lafarga, V., & Fernández-Capetillo, Ó. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821618-7.00266-2 · Cited by 3
Neuronal activity-dependent gene dysregulation in C9orf72 i 3 Neuronal models of ALS/FTD pathogenesis
Ghaffari, L., Welebob, E. M., Newton, S. E. B., Boehringer, A. V., Cyliax, K., Pasinelli, P., Trotti, D., & Haeusler, A. R. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00238.2025 · Cited by 2
The Tale of the Guanosine Tract in Repeat Expansion Disorders
Karati, S., Rawat, S., Kumari, A., Das, S., Shukla, S., & Kumar, A. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05735-w · Cited by 2
PAICS mediates DNA damage and cerebellar neuronal loss in C9orf72 amyotrophic lateral sclerosis
Singh, J., Lescouzères, L., Zaouter, C., Chaineau, M., Haghi, G., Durcan, T. M., & Patten, S. A. (2026) · Brain · doi:10.1093/brain/awag092 · Cited by 2
Monoaminergic Alterations at the Subregional Cervical and Thoracic Spinal Cord Level of Patients Within the FTD ‐ ALS Continuum and Early‐Onset AD : Low Thoracic Dopaminergic Activity in ALS
Heylen, A., Vermeiren, Y., Deyn, P. P. D., & Dam, D. V. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70046 · Cited by 2
The Development of Drug Therapies for Frontotemporal Dementia Caused by Progranulin Mutations
Muynck, L. D., & Damme, P. V. (2015) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781681080680115030007 · Cited by 2
The FTD-ALS spectrum
Bak, T. H., & Abrahams, S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781316091586.009 · Cited by 2
Cortical Manifestations in Amyotrophic Lateral Sclerosis
Moszczynski, A. J., & Strong, M. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801942-9.00009-4 · Cited by 3
Frontotemporal lobar degeneration
Kim, B., Viera-Ortiz, A., Phan, J. M., Irwin, D. J., & Lee, E. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00041-1 · Cited by 3
Making sense of the antisense transcripts in C9FTD/ALS
Todd, P. K. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1201-y · Cited by 2
Hippocampal protein aggregation signatures fully distinguish pathogenic and wildtype UBQLN2 in amyotrophic lateral sclerosisPreprint
Thumbadoo, K. M., Dieriks, B. V., Murray, H. C., Swanson, M. E. V., Yoo, J. H., Mehrabi, N. F., Turner, C. P., Dragunow, M., Faull, R. L. M., Curtis, M. A., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.12.475792 · Cited by 2
C9orf72 repeat expansion-carrying iPSC-microglia from FTD patients show increased phagocytic activity concomitantly with decreased number of autophagosomal-lysosomal vesiclesPreprint
Rostalski, H., Hietanen, T., Hoffmann, D. B., Heikkinen, S., Huber, N., Dhingra, A., Rodríguez-Nieto, S., Kuulasmaa, T., Ohtonen, S., Jäntti, H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.14.607573 · Cited by 3
Neuropathological analysis of an ALS patient carrying a SOD1 missense variant and a C9orf72 repeat expansion
Miki, T., Bertier, S. D., Amador, M. D. M., Nicolas, M., Guissart, C., Deret, M., Teyssou, E., Muratet, F., Bohl, D., Lobsiger, C. S., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03007-4 · Cited by 1

Authors: Mackenzie, I. R., Arzberger, T., Kremmer, E., Troost, D., Lorenzl, S., Mori, K., Weng, S.-M., Haass, C., Kretzschmar, H. A., Edbauer, D., & Neumann, M.
Affiliations: University of British Columbia (CA)
German Center for Neurodegenerative Diseases (DE)
Amsterdam UMC Location University of Amsterdam (NL)
Ludwig-Maximilians-Universität München (DE)
Adolf-Butenandt-Institut für Physiologische Chemie, Physikalische Biochemie und Zellbiologie (DE)
Institut für Neuropathologie (DE)
Corresponding author: Edbauer, Dieter
Neumann, Manuela
ORCID: Mackenzie, Ian R.
Lorenzl, Stefan
Mori, Kohji
Haass, Christian
Edbauer, Dieter
Neumann, Manuela
Venue: Acta Neuropathologica
Publisher: Springer Science and Business Media LLC
Published: 2013-10-06
Volume: 126
Issue: 6
Pages: 859-879
ISSN: 0001-6322 (ISSN-L)
1432-0533
DOI: 10.1007/s00401-013-1181-y
OpenAlex: W2092145129
Cited by: 345
References: 41
Citations by year: 2026: 8 · 2025: 17 · 2024: 17 · 2023: 19 · 2022: 16 · 2021: 31 · 2020: 31 · 2019: 36 · 2018: 36 · 2017: 43 · 2016: 26 · 2015: 34 · 2014: 29 · 2013: 2
FWCI: 19.25
Type: journal article
Language: en
Open access: green
hdl.handle.net
Licence: cc-by-nc-nd
www.springer.com/tdm (tdm)
Locations: Acta Neuropathologica (publishedVersion)
PubMed (publishedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
cIRcle (University of British Columbia) (submittedVersion, cc-by-nc-nd)
Site cant be reached (submittedVersion)
DZNE Pub (submittedVersion)
Pure Amsterdam UMC (submittedVersion)
Open Collections
Funders: Canadian Institutes of Health Research (74580)
Topics: Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: C9orf72 mutation, dipeptide repeat proteins, hexanucleotide repeat expansion, TDP-43 pathology, frontotemporal dementia, motor neuron disease, monoclonal antibodies, neurodegeneration, cerebellum, hippocampus, motor cortex, lower motor neurons, inclusion bodies, neuropathology
MeSH terms: C9orf72 Protein, Adult, Aged, Amyotrophic Lateral Sclerosis, Brain, DNA-Binding Proteins, Humans, Middle Aged, Mutation, Proteins, DNA Repeat Expansion, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks